{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T21:28:18Z","timestamp":1780435698938,"version":"3.54.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,6,3]],"date-time":"2024-06-03T00:00:00Z","timestamp":1717372800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,6,3]],"date-time":"2024-06-03T00:00:00Z","timestamp":1717372800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Singapore Ministry of Health\u2019s National Medical Research Council","award":["TA21jun-0005"],"award-info":[{"award-number":["TA21jun-0005"]}]},{"name":"Singapore Ministry of Health\u2019s National Medical Research Council","award":["SEEDFD21jun-0002"],"award-info":[{"award-number":["SEEDFD21jun-0002"]}]},{"name":"Singapore Ministry of Health\u2019s National Medical Research Council","award":["CG21APR2002"],"award-info":[{"award-number":["CG21APR2002"]}]},{"name":"SingHealth Duke-NUS AM\/ACP-Designated Philanthropic Fund Grant Award","award":["08\/FY2023\/EX\/27-A65"],"award-info":[{"award-number":["08\/FY2023\/EX\/27-A65"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Extramammary Paget\u2019s disease (EMPD) is a rare cancer that occurs within the epithelium of the skin, arising predominantly in areas with high apocrine gland concentration such as the vulva, scrotum, penis and perianal regions. Here, we aim to integrate clinicopathological data with genomic analysis of aggressive, rapidly-progressing <jats:italic>de novo<\/jats:italic> metastatic EMPD responding to HER2-directed treatment in combination with other agents, to attain a more comprehensive understanding of the disease landscape.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Immunohistochemical staining on the scrotal wall tumor and bone marrow metastasis demonstrated HER2 overexpression. Whole genome sequencing of the tumor and matched blood was performed.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Notable copy number gains (log<jats:sub>2<\/jats:sub>FC\u2009&gt;\u20090.9) on chromosomes 7 and 8 were detected (<jats:italic>n<\/jats:italic>\u2009=\u200981), with 92.6% of these unique genes specifically located on chromosome 8. Prominent cancer-associated genes include <jats:italic>ZNF703<\/jats:italic>, <jats:italic>HOOK3<\/jats:italic>, <jats:italic>DDHD2<\/jats:italic>, <jats:italic>LSM1<\/jats:italic>, <jats:italic>NSD3<\/jats:italic>, <jats:italic>ADAM9<\/jats:italic>, <jats:italic>BRF2<\/jats:italic>, <jats:italic>KAT6A<\/jats:italic> and <jats:italic>FGFR1.<\/jats:italic> Interestingly, <jats:italic>ERBB2<\/jats:italic> gene did not exhibit high copy number gain (log<jats:sub>2<\/jats:sub>FC\u2009=\u20090.4) although 90% of tumor cells stained HER2-positive. Enrichment in pathways associated with transforming growth factor-beta (TGF\u03b2) (FDR\u2009=\u20090.0376, Enrichment Ratio\u2009=\u20098.12) and fibroblast growth factor receptor (FGFR1) signaling (FDR\u2009=\u20090.0082, Enrichment Ratio\u2009=\u20092.3) was detected. Amplicon structure analysis revealed that this was a simple-linear amplification event.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Whole genome sequencing revealed the underlying copy number variation landscape in HER2-positive metastatic EMPD. The presence of alternative signalling pathways and genetic variants suggests potential interactions with HER2 signalling, which possibly contributed to the HER2 overexpression and observed response to HER2-directed therapy combined with other agents in a comprehensive treatment regimen.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13023-024-03169-y","type":"journal-article","created":{"date-parts":[[2024,6,3]],"date-time":"2024-06-03T14:07:50Z","timestamp":1717423670000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Whole genome sequencing of HER2-positive metastatic extramammary Paget\u2019s disease: a case report"],"prefix":"10.1186","volume":"19","author":[{"given":"Boon Yee","family":"Lim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zexi","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing Quan","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tun Kiat","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth Chun Yong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bavani","family":"Kannan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing Yi","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abner Herbert","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhimei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cedric Chuan-Young","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inny","family":"Busmanis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason Yongsheng","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,6,3]]},"reference":[{"key":"3169_CR1","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.jdermsci.2016.06.004","volume":"83","author":"K Ohara","year":"2016","unstructured":"Ohara K, Fujisawa Y, Yoshino K, Kiyohara Y, Kadono T, Murata Y, et al. A proposal for a TNM staging system for extramammary Paget disease: retrospective analysis of 301 patients with invasive primary tumors. J Dermatol Sci. 2016;83:234\u20139.","journal-title":"J Dermatol Sci"},{"key":"3169_CR2","doi-asserted-by":"crossref","unstructured":"Zattarin E, Nichetti F, Ligorio F, Mazzeo L, Lobefaro R, Fuc\u00e0 G et al. Case Report: prolonged clinical benefit with sequential trastuzumab-containing treatments in a patient with advanced extramammary paget disease of the groin. Front Oncol 2022;12.","DOI":"10.3389\/fonc.2022.925551"},{"key":"3169_CR3","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.3390\/cancers15061803","volume":"15","author":"G Caruso","year":"2023","unstructured":"Caruso G, Barcellini A, Mazzeo R, Gallo R, Vitale MG, Passarelli A, et al. Vulvar Paget\u2019s Disease: a systematic review of the MITO Rare Cancer Group. Cancers. 2023;15:1803.","journal-title":"Cancers"},{"key":"3169_CR4","doi-asserted-by":"crossref","unstructured":"St. Claire K, Hoover A, Ashack K, Khachemoune A. Extramammary Paget disease. Dermatol Online J 2019;25.","DOI":"10.5070\/D3254043591"},{"key":"3169_CR5","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s10911-011-9206-4","volume":"16","author":"A Chow","year":"2011","unstructured":"Chow A, Arteaga CL, Wang SE. When Tumor suppressor TGF\u03b2 meets the HER2 (ERBB2) Oncogene. J Mammary Gland Biol Neoplasia. 2011;16:81\u20138.","journal-title":"J Mammary Gland Biol Neoplasia"},{"key":"3169_CR6","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1097\/01.pdm.0000213456.30151.5b","volume":"15","author":"MK Bianco","year":"2006","unstructured":"Bianco MK, Vasef MA. HER-2 gene amplification in Paget Disease of the Nipple and Extramammary Site: a chromogenic in situ hybridization study. Diagn Mol Pathol. 2006;15:131.","journal-title":"Diagn Mol Pathol"},{"key":"3169_CR7","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1002\/cam4.2820","volume":"9","author":"Z Gatalica","year":"2020","unstructured":"Gatalica Z, Vranic S, Kru\u0161lin B, Poorman K, Stafford P, Kacerovska D, et al. Comparison of the biomarkers for targeted therapies in primary extra-mammary and mammary Paget\u2019s disease. Cancer Med. 2020;9:1441\u201350.","journal-title":"Cancer Med"},{"key":"3169_CR8","first-page":"2677","volume":"17","author":"X Lu","year":"2019","unstructured":"Lu X, Zhang P, Zhu Y, Ye D. Human epidermal growth factor receptor 2 amplification as a biomarker for treatment in patients with lymph node-metastatic penoscrotal extramammary Paget\u2019s disease. Oncol Lett. 2019;17:2677\u201386.","journal-title":"Oncol Lett"},{"key":"3169_CR9","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1046\/j.1523-1747.1999.00634.x","volume":"113","author":"M Takata","year":"1999","unstructured":"Takata M, Fujimoto A, Aoki H, Hatta N, Ooi A, Takehara K. erbB-2 overexpression but no activation of beta-catenin gene in extramammary Paget\u2019s disease. J Invest Dermatol. 1999;113:258\u201362.","journal-title":"J Invest Dermatol"},{"key":"3169_CR10","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1046\/j.1365-2559.2003.01648.x","volume":"42","author":"M Tanskanen","year":"2003","unstructured":"Tanskanen M, Jahkola T, Asko-Seljavaara S, Jalkanen J, Isola J. HER2 oncogene amplification in extramammary Paget\u2019s disease. Histopathology. 2003;42:575\u20139.","journal-title":"Histopathology"},{"key":"3169_CR11","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1002\/cncr.11656","volume":"98","author":"KS Klos","year":"2003","unstructured":"Klos KS, Zhou X, Lee S, Zhang L, Yang W, Nagata Y, et al. Combined trastuzumab and paclitaxel treatment better inhibits ErbB-2-mediated angiogenesis in breast carcinoma through a more effective inhibition of akt than either treatment alone. Cancer. 2003;98:1377\u201385.","journal-title":"Cancer"},{"key":"3169_CR12","doi-asserted-by":"publisher","first-page":"5867","DOI":"10.1038\/s41388-020-01404-x","volume":"39","author":"T Maeda","year":"2020","unstructured":"Maeda T, Kitamura S, Nishihara H, Yanagi T. Extramammary Paget\u2019s disease patient-derived xenografts harboring ERBB2 S310F mutation show sensitivity to HER2-targeted therapies. Oncogene. 2020;39:5867\u201375.","journal-title":"Oncogene"},{"key":"3169_CR13","first-page":"217","volume":"66","author":"E Rassy","year":"2022","unstructured":"Rassy E, Rached L, Pistilli B. Antibody drug conjugates targeting HER2: clinical development in metastatic breast cancer. Breast off J Eur Soc Mastology. 2022;66:217\u201326.","journal-title":"Breast off J Eur Soc Mastology"},{"key":"3169_CR14","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1159\/000333002","volume":"3","author":"F Hanawa","year":"2011","unstructured":"Hanawa F, Inozume T, Harada K, Kawamura T, Shibagaki N, Shimada S. A case of metastatic Extramammary Paget\u2019s Disease responding to Trastuzumab plus Paclitaxel Combination Therapy. Case Rep Dermatol. 2011;3:223\u20137. h.","journal-title":"Case Rep Dermatol"},{"key":"3169_CR15","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1111\/j.1346-8138.2009.00676.x","volume":"36","author":"S Takahagi","year":"2009","unstructured":"Takahagi S, Noda H, Kamegashira A, Madokoro N, Hori I, Shindo H, et al. Metastatic extramammary Paget\u2019s disease treated with paclitaxel and trastuzumab combination chemotherapy. J Dermatol. 2009;36:457\u201361.","journal-title":"J Dermatol"},{"key":"3169_CR16","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1111\/1346-8138.15515","volume":"47","author":"N Sekiguchi","year":"2020","unstructured":"Sekiguchi N, Kubota S, Noguchi T, Fukushima T, Kobayashi T, Kanda S, et al. Experiences of trastuzumab plus paclitaxel combination therapy in metastatic human epidermal growth factor receptor 2-positive extramammary Paget\u2019s disease: four cases and a review. J Dermatol. 2020;47:1276\u20139.","journal-title":"J Dermatol"},{"key":"3169_CR17","doi-asserted-by":"publisher","first-page":"63","DOI":"10.12688\/f1000research.16665.2","volume":"9","author":"M Garcia","year":"2020","unstructured":"Garcia M, Juhos S, Larsson M, Olason PI, Martin M, Eisfeldt J, et al. Sarek: a portable workflow for whole-genome sequencing analysis of germline and somatic variants. F1000Research. 2020;9:63.","journal-title":"F1000Research"},{"key":"3169_CR18","unstructured":"Simon A. FastQC: a quality control tool for high throughput sequence data. 2010."},{"key":"3169_CR19","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","volume":"25","author":"H Li","year":"2009","unstructured":"Li H, Durbin R. Fast and accurate short read alignment with Burrows\u2013Wheeler transform. Bioinformatics. 2009;25:1754\u201360.","journal-title":"Bioinformatics"},{"key":"3169_CR20","unstructured":"van der Auwera G, O\u2019Connor BD. Genomics in the cloud: using Docker, GATK, and WDL in Terra. First edition. Sebastopol, CA: O\u2019Reilly Media; 2020."},{"key":"3169_CR21","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1101\/gr.8.3.175","volume":"8","author":"B Ewing","year":"1998","unstructured":"Ewing B, Hillier L, Wendl MC, Green P. Base-calling of automated sequencer traces using Phred I. Accuracy Assessment. Genome Res. 1998;8:175\u201385.","journal-title":"Genome Res"},{"key":"3169_CR22","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1101\/gr.107524.110","volume":"20","author":"A McKenna","year":"2010","unstructured":"McKenna A, Hanna M, Banks E, Sivachenko A, Cibulskis K, Kernytsky A, et al. The genome analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res. 2010;20:1297\u2013303.","journal-title":"Genome Res"},{"key":"3169_CR23","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1093\/bioinformatics\/btp352","volume":"25","author":"H Li","year":"2009","unstructured":"Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, Homer N, et al. The sequence Alignment\/Map format and SAMtools. Bioinformatics. 2009;25:2078\u20139.","journal-title":"Bioinformatics"},{"key":"3169_CR24","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1093\/bioinformatics\/btx699","volume":"34","author":"BS Pedersen","year":"2018","unstructured":"Pedersen BS, Quinlan AR. Mosdepth: quick coverage calculation for genomes and exomes. Bioinformatics. 2018;34:867\u20138.","journal-title":"Bioinformatics"},{"key":"3169_CR25","doi-asserted-by":"publisher","first-page":"3047","DOI":"10.1093\/bioinformatics\/btw354","volume":"32","author":"P Ewels","year":"2016","unstructured":"Ewels P, Magnusson M, Lundin S, K\u00e4ller M. MultiQC: summarize analysis results for multiple tools and samples in a single report. Bioinforma Oxf Engl. 2016;32:3047\u20138.","journal-title":"Bioinforma Oxf Engl"},{"key":"3169_CR26","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/nbt.2514","volume":"31","author":"K Cibulskis","year":"2013","unstructured":"Cibulskis K, Lawrence MS, Carter SL, Sivachenko A, Jaffe D, Sougnez C, et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat Biotechnol. 2013;31:213\u20139.","journal-title":"Nat Biotechnol"},{"key":"3169_CR27","first-page":"122","volume":"17","author":"W McLaren","year":"2016","unstructured":"McLaren W, Gil L, Hunt SE, Riat HS, Ritchie GRS, Thormann A, et al. Ensembl Variant Effect Predictor Genome Biol. 2016;17:122.","journal-title":"Ensembl Variant Effect Predictor Genome Biol"},{"key":"3169_CR28","unstructured":"Rozen SG. mSigAct 2023."},{"key":"3169_CR29","doi-asserted-by":"publisher","first-page":"e1004873","DOI":"10.1371\/journal.pcbi.1004873","volume":"12","author":"E Talevich","year":"2016","unstructured":"Talevich E, Shain AH, Botton T, Bastian BC. CNVkit: genome-wide Copy Number Detection and visualization from targeted DNA sequencing. PLOS Comput Biol. 2016;12:e1004873.","journal-title":"PLOS Comput Biol"},{"key":"3169_CR30","doi-asserted-by":"publisher","first-page":"W199","DOI":"10.1093\/nar\/gkz401","volume":"47","author":"Y Liao","year":"2019","unstructured":"Liao Y, Wang J, Jaehnig EJ, Shi Z, Zhang B. WebGestalt 2019: gene set analysis toolkit with revamped UIs and APIs. Nucleic Acids Res. 2019;47:W199\u2013205.","journal-title":"Nucleic Acids Res"},{"key":"3169_CR31","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/nprot.2008.211","volume":"4","author":"DW Huang","year":"2009","unstructured":"Huang DW, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 2009;4:44\u201357.","journal-title":"Nat Protoc"},{"key":"3169_CR32","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1038\/s41467-018-08200-y","volume":"10","author":"V Deshpande","year":"2019","unstructured":"Deshpande V, Luebeck J, Nguyen N-PD, Bakhtiari M, Turner KM, Schwab R, et al. Exploring the landscape of focal amplifications in cancer using AmpliconArchitect. Nat Commun. 2019;10:392.","journal-title":"Nat Commun"},{"key":"3169_CR33","doi-asserted-by":"publisher","first-page":"D970","DOI":"10.1093\/nar\/gks937","volume":"41","author":"M Zhao","year":"2013","unstructured":"Zhao M, Sun J, Zhao Z. TSGene: a web resource for tumor suppressor genes. Nucleic Acids Res. 2013;41:D970\u20136.","journal-title":"Nucleic Acids Res"},{"key":"3169_CR34","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1097\/00000372-197900120-00002","volume":"1","author":"RE Jones","year":"1979","unstructured":"Jones RE, Austin C, Ackerman AB. Extramammary Paget\u2019s disease. A critical reexamination. Am J Dermatopathol. 1979;1:101\u201332. https:\/\/doi.org\/10.1097\/00000372-197900120-00002.","journal-title":"Am J Dermatopathol"},{"key":"3169_CR35","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.canlet.2020.10.004","volume":"496","author":"R Sundaramoorthy","year":"2021","unstructured":"Sundaramoorthy R, Murugan A, Nakoaka H, Inoue I. APOBEC: a molecular driver in cervical cancer pathogenesis. Cancer Lett. 2021;496:104\u201316.","journal-title":"Cancer Lett"},{"key":"3169_CR36","doi-asserted-by":"publisher","first-page":"81","DOI":"10.3747\/co.v16i5.374","volume":"16","author":"KM Beleznay","year":"2009","unstructured":"Beleznay KM, Levesque MA, Gill S. Response to 5-fluorouracil in metastatic extramammary paget disease of the scrotum presenting as pancytopenia and back pain. Curr Oncol. 2009;16:81\u20133.","journal-title":"Curr Oncol"},{"key":"3169_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3941\/jrcr.v10i5.2577","volume":"10","author":"JT Little","year":"2016","unstructured":"Little JT, Lehman VT, Morris JM, Lehman JS, Diehn FE. Spinal metastases of Extramammary Paget Disease with radiologic-pathologic correlation. J Radiol Case Rep. 2016;10:1\u20138.","journal-title":"J Radiol Case Rep"},{"key":"3169_CR38","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1136\/jcp.2010.077446","volume":"63","author":"CE Richter","year":"2010","unstructured":"Richter CE, Hui P, Buza N, Silasi D-A, Azodi M, Santin AD, et al. HER-2\/NEU overexpression in vulvar paget disease: the Yale experience. J Clin Pathol. 2010;63:544\u20137.","journal-title":"J Clin Pathol"},{"key":"3169_CR39","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1111\/bjd.12249","volume":"168","author":"R Tanaka","year":"2013","unstructured":"Tanaka R, Sasajima Y, Tsuda H, Namikawa K, Tsutsumida A, Otsuka F, et al. Human epidermal growth factor receptor 2 protein overexpression and gene amplification in extramammary Paget disease. Br J Dermatol. 2013;168:1259\u201366.","journal-title":"Br J Dermatol"},{"key":"3169_CR40","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.3390\/diagnostics10121040","volume":"10","author":"G Angelico","year":"2020","unstructured":"Angelico G, Santoro A, Inzani F, Straccia P, Arciuolo D, Mul\u00e8 A, et al. Hormonal environment and HER2 status in Extra-mammary Paget\u2019s Disease (eMPD): a systematic literature review and Meta-analysis with clinical considerations. Diagnostics. 2020;10:1040.","journal-title":"Diagnostics"},{"key":"3169_CR41","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1111\/j.1365-2133.2005.06865.x","volume":"153","author":"K Yoneyama","year":"2005","unstructured":"Yoneyama K, Kamada N, Kinoshita K, Kawashima T, Otani M, Endo H, et al. Androgen-deprivation regimen for multiple bone metastases of extramammary Paget disease. Br J Dermatol. 2005;153:853\u20135.","journal-title":"Br J Dermatol"},{"key":"3169_CR42","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1038\/modpathol.3800437","volume":"18","author":"B Liegl","year":"2005","unstructured":"Liegl B, Horn L-C, Moinfar F. Androgen receptors are frequently expressed in mammary and extramammary Paget\u2019s disease. Mod Pathol. 2005;18:1283\u20138.","journal-title":"Mod Pathol"},{"key":"3169_CR43","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.2353\/ajpath.2009.090420","volume":"175","author":"S Hirakawa","year":"2009","unstructured":"Hirakawa S, Detmar M, Kerjaschki D, Nagamatsu S, Matsuo K, Tanemura A, et al. Nodal lymphangiogenesis and metastasis: role of tumor-induced lymphatic vessel activation in extramammary Paget\u2019s disease. Am J Pathol. 2009;175:2235\u201348.","journal-title":"Am J Pathol"},{"key":"3169_CR44","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.ceb.2014.09.001","volume":"31","author":"R Derynck","year":"2014","unstructured":"Derynck R, Muthusamy BP, Saeteurn KY. Signaling pathway cooperation in TGF-\u03b2-induced epithelial\u2013mesenchymal transition. Curr Opin Cell Biol. 2014;31:56\u201366.","journal-title":"Curr Opin Cell Biol"},{"key":"3169_CR45","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.jdermsci.2017.03.012","volume":"87","author":"Z Cho","year":"2017","unstructured":"Cho Z, Konishi E, Kanemaru M, Isohisa T, Arita T, Kawai M, et al. Podoplanin expression in peritumoral keratinocytes predicts aggressive behavior in extramammary Paget\u2019s disease. J Dermatol Sci. 2017;87:29\u201335.","journal-title":"J Dermatol Sci"},{"key":"3169_CR46","doi-asserted-by":"publisher","first-page":"6856","DOI":"10.3390\/ijms21186856","volume":"21","author":"A De Luca","year":"2020","unstructured":"De Luca A, Esposito Abate R, Rachiglio AM, Maiello MR, Esposito C, Schettino C, et al. FGFR fusions in Cancer: from Diagnostic approaches to therapeutic intervention. Int J Mol Sci. 2020;21:6856.","journal-title":"Int J Mol Sci"},{"key":"3169_CR47","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1038\/s41416-020-01157-0","volume":"124","author":"MA Krook","year":"2021","unstructured":"Krook MA, Reeser JW, Ernst G, Barker H, Wilberding M, Li G, et al. Fibroblast growth factor receptors in cancer: genetic alterations, diagnostics, therapeutic targets and mechanisms of resistance. Br J Cancer. 2021;124:880\u201392.","journal-title":"Br J Cancer"},{"key":"3169_CR48","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1158\/1078-0432.CCR-20-3205","volume":"27","author":"Y Ishida","year":"2021","unstructured":"Ishida Y, Kakiuchi N, Yoshida K, Inoue Y, Irie H, Kataoka TR, et al. Unbiased detection of driver mutations in Extramammary Paget Disease. Clin Cancer Res off J Am Assoc Cancer Res. 2021;27:1756\u201365.","journal-title":"Clin Cancer Res off J Am Assoc Cancer Res"},{"key":"3169_CR49","doi-asserted-by":"publisher","first-page":"807271","DOI":"10.3389\/fimmu.2022.807271","volume":"13","author":"F Peyraud","year":"2022","unstructured":"Peyraud F, Guegan J-P, Bodet D, Cousin S, Bessede A, Italiano A. Targeting Tryptophan Catabolism in Cancer Immunotherapy Era: challenges and perspectives. Front Immunol. 2022;13:807271.","journal-title":"Front Immunol"},{"key":"3169_CR50","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1159\/000514345","volume":"14","author":"BJ Guercio","year":"2021","unstructured":"Guercio BJ, Iyer G, Kidwai WZ, Lacouture ME, Ghafoor S, Rossi AM, et al. Treatment of metastatic Extramammary Paget Disease with Combination Ipilimumab and Nivolumab: a Case Report. Case Rep Oncol. 2021;14:430\u20138.","journal-title":"Case Rep Oncol"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-024-03169-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-024-03169-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-024-03169-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,3]],"date-time":"2024-06-03T15:05:04Z","timestamp":1717427104000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-024-03169-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,3]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3169"],"URL":"https:\/\/doi.org\/10.1186\/s13023-024-03169-y","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,3]]},"assertion":[{"value":"20 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent from the patient for use of biospecimens and clinical data was obtained in accordance with the Declaration of Helsinki. Tissue collection and consent protocols were under ethics approval from the SingHealth Centralized Institution Review Board (2010\/426\/B).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent has been obtained from the patient to publish this paper.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"223"}}